Lack of interaction between sertraline and lamotrigine in psychiatric patients: A retrospective study

Pharmacopsychiatry

Volumn 45, Issue 3, 2012, Pages 119-121

  Christensen, J ^a,b   Sandgaard, A P ^b   Sidenius, P ^a   Linnet, K ^c   Licht, R W ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

antidepressants; drug interactions; lamotrigine (lamictal); pharmacokinetics; selective serotonin reuptake inhibitors (SSRIs)

Indexed keywords

LAMOTRIGINE; SERTRALINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL PATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEADY STATE; STUDENT T TEST;

ADULT; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SERTRALINE; TRIAZINES;

EID: 84861228163     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0031-1297975     Document Type: Article

References (10)

1. Calabrese J R, Bowden C L, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry: 2003; 64 1013 1024 (Pubitemid 37158246)
2. Licht R W, Nielsen J N, Gram L F et al. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6 trial of the Danish University Antidepressant Group (DUAG-6). Bipolar Disord: 2010; 12 483 493
3. Dickins M, Chen C. Lamotrigine. Chemistry, Biotransformation and Pharmacokinetics. In: Levy R H, Mattson R H, Meldrum B S, Perucca E. editors. Antiepileptic Drugs. Fifth Edition ed. Philidelphia Lippincott, Williams & Wilkins: 2002; 370 379
4. Rowland A, Elliot D J, Williams J A et al. In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction. Drug Metab Dispos: 2006; 34 1055 1062 (Pubitemid 43763765)
5. Cipriani A, Brambilla P, Furukawa T et al. Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev October: 2005; 19 04 CD004185
6. Obach R S, Cox L M, Tremaine L M. Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study. Drug Metab Dispos: 2005; 33 262 270 (Pubitemid 40216594)
7. GlaxoSmithKline Lamictal prescribing information. 2007. http://us.gsk.com/products/assets/us-lamictal.pdf
8. Kaufman K R, Gerner R. Lamotrigine toxicity secondary to sertraline. Seizure: 1998; 7 163 165 (Pubitemid 28226943)
9. Gidal B E, Sheth R, Parnell J et al. Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy. Epilepsy Res: 2003; 57 85 93 (Pubitemid 38167725)
10. Reimers A, Skogvoll E, Sund J K et al. Drug interactions between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service. J Clin Psychopharmacol: 2005; 25 342 348 (Pubitemid 41060254)